CDK5 inhibition in vitro and in vivo induces cell death in myeloma and overcomes the obstacle of bortezomib resistance.
Tang H, Xu L, Cen X, Yang L, Feng J, Li G, Zhu H, Gao S, Yu Y, Zhao Y, Tian Z, Hou L, Yu S, Gao G.
Tang H, et al. Among authors: yu s, yu y.
Int J Mol Med. 2020 Jun;45(6):1661-1672. doi: 10.3892/ijmm.2020.4553. Epub 2020 Mar 26.
Int J Mol Med. 2020.
PMID: 32236619
Free PMC article.